Sonder Capital, a healthcare venture capital firm focused on transforming standards of care, announced the closing of its second fund, Futures II. The fund includes participation from major healthcare systems, including Mayo Clinic and Sutter Health, underscoring growing institutional interest in technologies that enhance patient access, improve care quality, and reshape the overall healthcare experience.
Futures II is anchored in an investment strategy centered on AI-enabled medical robotics and minimally invasive therapies. The fund aims to support companies building new care pathways and business models that expand where and how care can be delivered. By targeting innovations that enable treatment in more distributed settings, Sonder Capital is backing solutions designed to shift what conditions can be treated, who can deliver care, and where those interventions can occur.
The collaboration with leading healthcare systems is intended to provide portfolio companies with direct insights from frontline care environments, helping ensure that emerging technologies translate effectively into real-world clinical improvements.
Sonder Capital, co-founded in 2019 by Jay Watkins and Fred Moll, MD, brings together a team with experience in building and scaling healthcare companies. The firm’s track record includes involvement with companies such as Intuitive Surgical, Guidant Corporation, Shockwave Medical, Procept Biorobotics, Auris Health, and Reflexion Medical. Its investor base spans global industry leaders, family offices, and high-net-worth individuals focused on advancing healthcare innovation.
KEY QUOTES:
“Through our second fund we’ll continue enabling the next wave of companies and healthcare technologies reshaping medicine. And through our collaboration with Mayo Clinic and Sutter Health, we’re strengthening our ability to support portfolio companies with insights from frontline care delivery, helping founders ensure innovation directly translates into better patient care.”
Kate Garrett, Managing Partner at Sonder Capital
“Medical robotics has already transformed what’s possible in the operating room, and we’re now entering the next chapter. The addition of AI is unlocking new levels of performance and automation across care pathways, accelerating a revolution that will benefit patients, clinicians, and health systems alike, around the world.”
Fred Moll, MD, Founding Partner at Sonder Capital
